Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06342557 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transitional ePRO Diary Liver (Transitional-ePRO)

Study acronym: MACROLIVER
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Study title expanded, about 1 wordv6
  2. Minor Study Identification, Study Statusv5
  3. Minor Site details revisedv4
  4. Notable Start date: Feb 21, 2024 to Mar 28, 2024v3
  5. Notable Primary endpoint revisedv2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is part of the MACROLIVER Project, whose main objective is to create a digital tool for patients and caregivers for the management of liver disease that allows the optimization of therapy and/or the treatment process, even remotely. Such a tool not only reduces the movement of patients who are by definition fragile, but also enables the optimization of access and care by a multidisciplinary team. This tool is intended to support doctors and patients, but in no way replaces normal clinical practice. This study aims to explore the specificities of patients experiencing the transition from the pediatric ward to the adult ward in order to identify risk and protective factors that influence psychological well-being at both an individual and relational level. In order to gather all the information about the patients attending the transitional clinic and to obtain a more complete and truthful clinical-psychological picture, the study also includes the collection of retrospective data of the transplanted patients.
Trial Details
NCT Number NCT06342557
Lead Sponsor FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Conditions
(from sponsor)
Liver Transplant
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov